282 related articles for article (PubMed ID: 25611301)
1. MicroRNA in radiotherapy: miRage or miRador?
Korpela E; Vesprini D; Liu SK
Br J Cancer; 2015 Mar; 112(5):777-82. PubMed ID: 25611301
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 is a novel promising target in cancer radiation therapy.
Liu J; Zhu H; Yang X; Ge Y; Zhang C; Qin Q; Lu J; Zhan L; Cheng H; Sun X
Tumour Biol; 2014 May; 35(5):3975-9. PubMed ID: 24446181
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy.
Cellini F; Morganti AG; Genovesi D; Silvestris N; Valentini V
Molecules; 2014 Apr; 19(4):5379-401. PubMed ID: 24879584
[TBL] [Abstract][Full Text] [Related]
5. Large scale in vivo micro-RNA loss of function screen identified miR-29a, miR-100 and miR-155 as modulators of radioresistance and tumor-stroma communication.
Fahim Golestaneh A; Lecker LSM; Schlegel J; Nowrouzi A; Schwager C; Meister S; Weichert W; Debus J; Abdollahi A
Int J Cancer; 2019 Jun; 144(11):2774-2781. PubMed ID: 30478850
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and Their Impact on Radiotherapy for Cancer.
Mueller AK; Lindner K; Hummel R; Haier J; Watson DI; Hussey DJ
Radiat Res; 2016 Jun; 185(6):668-77. PubMed ID: 27223830
[TBL] [Abstract][Full Text] [Related]
7. Individual Response to Ionizing Radiation and Personalized Radiotherapy.
Domina EA; Philchenkov A; Dubrovska A
Crit Rev Oncog; 2018; 23(1-2):69-92. PubMed ID: 29953368
[TBL] [Abstract][Full Text] [Related]
8. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
Zhang P; Wang L; Rodriguez-Aguayo C; Yuan Y; Debeb BG; Chen D; Sun Y; You MJ; Liu Y; Dean DC; Woodward WA; Liang H; Yang X; Lopez-Berestein G; Sood AK; Hu Y; Ang KK; Chen J; Ma L
Nat Commun; 2014 Dec; 5():5671. PubMed ID: 25476932
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells and signaling pathways in radioresistance.
Chang L; Graham P; Hao J; Ni J; Deng J; Bucci J; Malouf D; Gillatt D; Li Y
Oncotarget; 2016 Mar; 7(10):11002-17. PubMed ID: 26716904
[TBL] [Abstract][Full Text] [Related]
10. Emergence of miR-34a in radiation therapy.
Lacombe J; Zenhausern F
Crit Rev Oncol Hematol; 2017 Jan; 109():69-78. PubMed ID: 28010900
[TBL] [Abstract][Full Text] [Related]
11. miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status.
Li W; Guo F; Wang P; Hong S; Zhang C
Curr Mol Med; 2014 Jan; 14(1):185-95. PubMed ID: 24295494
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA and signal transduction pathways in tumor radiation response.
Zhao L; Lu X; Cao Y
Cell Signal; 2013 Jul; 25(7):1625-34. PubMed ID: 23602933
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of microRNA-1323 restores sensitivity to radiation by suppression of PRKDC activity in radiation-resistant lung cancer cells.
Li Y; Han W; Ni TT; Lu L; Huang M; Zhang Y; Cao H; Zhang HQ; Luo W; Li H
Oncol Rep; 2015 Jun; 33(6):2821-8. PubMed ID: 25823795
[TBL] [Abstract][Full Text] [Related]
14. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment.
Nijkamp MM; Span PN; Bussink J; Kaanders JH
Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma.
Lynam-Lennon N; Reynolds JV; Marignol L; Sheils OM; Pidgeon GP; Maher SG
J Mol Med (Berl); 2012 Dec; 90(12):1449-58. PubMed ID: 22706599
[TBL] [Abstract][Full Text] [Related]
16. miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA.
Ray J; Haughey C; Hoey C; Jeon J; Murphy R; Dura-Perez L; McCabe N; Downes M; Jain S; Boutros PC; Mills IG; Liu SK
Cancer Lett; 2020 Mar; 473():107-117. PubMed ID: 31874245
[TBL] [Abstract][Full Text] [Related]
17. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
[TBL] [Abstract][Full Text] [Related]
18. Early and late radiation effects in healthy tissues of oncologic patients under therapeutic irradiations.
Domina EA
Probl Radiac Med Radiobiol; 2017 Dec; 22():23-37. PubMed ID: 29286495
[TBL] [Abstract][Full Text] [Related]
19. Lysosomes contribute to radioresistance in cancer.
Zhang X; Wang J; Li X; Wang D
Cancer Lett; 2018 Dec; 439():39-46. PubMed ID: 30217567
[TBL] [Abstract][Full Text] [Related]
20. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
